Elawyers Elawyers
Washington| Change

Center for Food Safety v. Azar, 4:18-cv-06299-YGR. (2019)

Court: District Court, N.D. California Number: infdco20190612a51 Visitors: 10
Filed: Jun. 11, 2019
Latest Update: Jun. 11, 2019
Summary: FEE STIPULATION AND ORDER YVONNE GONZALEZ ROGERS , District Judge . IT IS HEREBY STIPULATED AND AGREED by and between the Plaintiffs on the one hand (the Center for Food Safety and the Center for Environmental Health) and the Defendants on the other (Alex M. Azar, Secretary of the United States Department of Health and Human Services; Norman E. Sharpless, Acting Commissioner of Food and Drugs, U.S. Food and Drug Administration (FDA); and the United States Department of Health and Human Serv
More

FEE STIPULATION AND ORDER

IT IS HEREBY STIPULATED AND AGREED by and between the Plaintiffs on the one hand (the Center for Food Safety and the Center for Environmental Health) and the Defendants on the other (Alex M. Azar, Secretary of the United States Department of Health and Human Services; Norman E. Sharpless, Acting Commissioner of Food and Drugs, U.S. Food and Drug Administration (FDA); and the United States Department of Health and Human Services (HHS)); and

IT IS HEREBY ORDERED that Plaintiffs are to be awarded the sum of $45,227.35 in attorneys' fees, expenses, and costs pursuant to the Equal Access to Justice Act, 28 U.S.C. § 2412.

Within sixty (60) days after the Court endorses and "so orders" this Stipulation, FDA and/or HHS shall remit the amount of $43,071.99 to the Center for Food Safety in full satisfaction of Plaintiffs' fees and expenses. Such amount shall be remitted by Electronic Funds Transfer to an account to be specified by counsel for the Plaintiffs, and said counsel shall provide to counsel for the Defendants, within five business days after the Court endorses and "so orders" this Stipulation and Order, all information necessary for FDA and/or HHS to effectuate the Electronic Funds Transfer.

In addition, within ten days after the Court endorses and "so orders" this Stipulation and Order, the Department of Justice will submit a request to the Judgment Fund for immediate payment of $2,155.36 to the Plaintiffs in full satisfaction of Plaintiffs' claim for costs incurred in this matter. Assuming that the United States Treasury officials who administer the Judgment Fund determine that payment of the settled costs is properly made from the Judgment Fund, payment will be made either by a United States Treasury check, payable to the Center for Food Safety, or by an Electronic Funds Transfer.

The payments described in the preceding paragraphs shall be the full and final settlement of any and all claims that any of the Plaintiffs, and any of their current or former attorneys, and any of their respective heirs, executors, successors, and assigns, may now have or may hereafter acquire against the Defendants, and/or against FDA or the United States of America, pursuant to any statute or rule or regulation, for attorneys' fees, expenses, or costs incurred in connection with this action, with the exception of any future action brought to enforce the consent decree entered by the Court. Other than what is specifically set forth in this Stipulation and Order, the Plaintiffs and their counsel expressly waive and release the Defendants, FDA, and the United States of America from all claims and liability for attorneys' fees, expenses, and costs that Plaintiffs or their current or former counsel may now have or may hereafter acquire in connection with any and all claims and causes of action that were or have been asserted in this action, or concerning any of the matters alleged in this action, with the exception of any future action brought to enforce the Consent Decree entered by the Court. "Future action[s] brought to enforce the Consent Decree" includes but is not limited to Plaintiffs' right to seek further EAJA reimbursement in the event that: (1) Defendant moves the Court for an extension of time for one or more of the FSMA deadlines established by the Consent Decree; (2) Plaintiffs disagree that such an extension is warranted and file an opposition to Defendant's motion; and (3) the Court denies Defendant's motion.

This Stipulation and Order shall not be construed to include a finding or concession that the position of the Defendants, FDA, or the United States of America or their counsel in this litigation, or in the events leading up to this litigation, was not substantially justified, or that the Defendants, FDA, or the United States of America are liable as a matter of law for the payment of any attorneys' fees, expenses, or costs. The provision for attorneys' fees, expenses, and costs in this Stipulation and Order is solely by agreement of the parties and shall not serve as precedent in any other case.

FootNotes


1. Norman E. Sharpless, M.D. became Acting Commissioner of Food and Drugs on April 5, 2019. By operation of Fed. R. Civ. P. 25(d), Dr. Sharpless is automatically substituted as a party for former Commissioner of Food and Drugs, Scott Gottlieb, M.D.
Source:  Leagle

Can't find what you're looking for?

Post a free question on our public forum.
Ask a Question
Search for lawyers by practice areas.
Find a Lawyer